{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:56:07Z","timestamp":1792659367278,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ajog.2018.05.018","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T12:56:24Z","timestamp":1527684984000},"page":"300.e1-300.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs"],"prefix":"10.1016","volume":"219","author":[{"given":"A.","family":"Santamaria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alibrandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Di Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Pintaudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Facchinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"D\u2019Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2018.05.018_bib1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00006250-200109000-00037","article-title":"Gestational diabetes. ACOG Practice Bulletin no. 30","volume":"98","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.018_bib2","article-title":"Hyperglycaemia and risk of adverse perinatal outcomes: systematic reviews and meta-analysis","volume":"13","author":"Farrar","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2018.05.018_bib3","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"Metzger","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2018.05.018_bib4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc09-1848","article-title":"International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2018.05.018_bib5","first-page":"CD010443","article-title":"Diet and exercise interventions for preventing gestational diabetes mellitus","volume":"4","author":"Bain","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2018.05.018_bib6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/1471-0528.13764","article-title":"Development of composite outcomes for individual patient data (IPD) meta-analysis on the effects of diet and lifestyle in pregnancy: a Delphi survey","volume":"123","author":"Ragozinska","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2018.05.018_bib7","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1097\/AOG.0000000000002159","article-title":"Practice Bulletin no.180: gestational diabetes mellitus","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.018_bib8","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2018.01.041","article-title":"SMFM statement: pharmacological treatment of gestational diabetes. SMFM Publications Committee","volume":"218","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.018_bib9","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM200010193431601","article-title":"A\u00a0comparison of glyburide and insulin in women with gestational diabetes mellitus","volume":"343","author":"Langer","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2018.05.018_bib10","doi-asserted-by":"crossref","first-page":"e4526","DOI":"10.1097\/MD.0000000000004526","article-title":"Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome","volume":"95","author":"Zeng","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajog.2018.05.018_bib11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3109\/09513590.2015.1041906","article-title":"Efficacy of metformin on pregnancy complications in women with polycystic ovary syndrome: a meta-analysis","volume":"31","author":"Feng","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2018.05.018_bib12","doi-asserted-by":"crossref","first-page":"e1604","DOI":"10.1097\/MD.0000000000001604","article-title":"Relationship between myo-inositol supplementary and gestational diabetes mellitus: a meta-analysis","volume":"94","author":"Zheng","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajog.2018.05.018_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jdiacomp.2017.07.007","article-title":"Myo-inositol lowers the risk of developing gestational diabetes mellitus in pregnancy: a systematic reviews and meta-analysis of randomized controlled trials with trial sequential analysis","volume":"32","author":"Guo","year":"2018","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.ajog.2018.05.018_bib14","first-page":"CD011507","article-title":"Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes","volume":"12","author":"Crawford","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2018.05.018_bib15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2119\/molmed.2010.00107","article-title":"D-chiro inositol glycans in insulin signaling and insulin resistance","volume":"16","author":"Larner","year":"2010","journal-title":"Mol Med"},{"key":"10.1016\/j.ajog.2018.05.018_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2337\/dc12-2505","article-title":"Can a dietary supplement prevent gestational diabetes mellitus?","volume":"36","author":"Coustan","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2018.05.018_bib17","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/09513590701672405","article-title":"Myo-inositol in patients with polycystic ovary syndrome","volume":"23","author":"Papaleo","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2018.05.018_bib18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/gme.0b013e3181e8e1b1","article-title":"Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study","volume":"18","author":"Giordano","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.ajog.2018.05.018_bib19","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1464-5491.2011.03284.x","article-title":"The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes","volume":"28","author":"Corrado","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.ajog.2018.05.018_bib20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3109\/09513590.2011.633665","article-title":"Myo-inositol may prevent gestational diabetes in PCOS women","volume":"28","author":"D\u2019Anna","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2018.05.018_bib21","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2337\/dc12-1371","article-title":"Myo-inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes","volume":"36","author":"D\u2019Anna","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2018.05.018_bib22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/AOG.0000000000000958","article-title":"Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial","volume":"126","author":"D\u02bcAnna","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.05.018_bib23","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.3109\/14767058.2015.1121478","article-title":"Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial","volume":"29","author":"Santamaria","year":"2016","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2018.05.018_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MPG.0b013e3181da213e","article-title":"Neonatal anthropometric charts: the Italian neonatal study compared with other European studies","volume":"51","author":"Bertino","year":"2010","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ajog.2018.05.018_bib25","first-page":"931","article-title":"Inositol safety: clinical evidences","volume":"15","author":"Carlomagno","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ajog.2018.05.018_bib26","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3109\/14767058.2013.766691","article-title":"Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized, controlled trial","volume":"26","author":"Matarrelli","year":"2013","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2018.05.018_bib27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2337\/dc16-2449","article-title":"The prevention of gestational diabetes mellitus with antenatal oral inositol supplementation: a randomized, controlled trial","volume":"40","author":"Farren","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2018.05.018_bib28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1509819","article-title":"Metformin versus placebo in obese pregnant women without diabetes mellitus","volume":"374","author":"Syngelaki","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2018.05.018_bib29","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.biochi.2013.05.011","article-title":"Potential role and therapeutic interest of myo-inositol in metabolic diseases","volume":"95","author":"Croze","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.ajog.2018.05.018_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin Sci (Lond)"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937818304289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937818304289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:20:37Z","timestamp":1757589637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937818304289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0002937818304289"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2018.05.018","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2018.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}